Synergy San Diego Site — Lemon Grove, California

Synergy San Diego Site is a clinical research site located in Lemon Grove, California, United States 91945.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Synergy San Diego Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lemon Grove

Browse all research sites in California · View every site in Lemon Grove

• Synergy San Diego
• Synergy East
• Clinical Site
• Neurocrine Clinical Site
• Alkermes Investigational Site
• Sage Investigational Site
• Synergy Clinical Research Center of Escondido
• Synergy Research San Diego
• Synergy
• Pacific Research Network
• Teva Investigational Site 14771
• Synergy Clinical Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synergy San Diego Site?

Synergy San Diego Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synergy San Diego Site conducted?

Synergy San Diego Site has 1 clinical trials on record, with 1 currently active. Their work covers Schizophrenia.

Is Synergy San Diego Site accredited by Crixeo Clinical Trials?

Synergy San Diego Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synergy San Diego Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.